Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles

Isaac Lavie, Gautam G. Rao, Diego H. Castrillon, David S. Miller, John O. Schorge

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objective: Partial hydatidiform moles infrequently progress to gestational trophoblastic neoplasia. The purpose of this study was to determine the optimal duration of human chorionic gonadotropin surveillance. Study design: We retrospectively reviewed the clinical follow-up of all women who were diagnosed with partial hydatidiform mole at our institution from 1983 to 2003. Results: One hundred sixty-three patients were identified with a median age of 23 years (range, 14-42 years). Seventy-four patients (45%) attained undetectable levels of human chorionic gonadotropin; none of the patients had gestational trophoblastic neoplasia. Forty patients completed the 6 months of recommended follow-up; 6 patients conceived during surveillance, and 28 patients did not return for any further office visits 1 to 5 months after achieving remission. Eighty-three patients (51%) were lost to follow-up before normalization of human chorionic gonadotropin. Six women (4%) had stage I gestational trophoblastic neoplasia during surveillance. Conclusion: Our results support the suggestion that a single undetectable human chorionic gonadotropin level after evacuation is sufficient follow-up to ensure remission in patients with partial hydatidiform moles.

Original languageEnglish (US)
Pages (from-to)1362-1364
Number of pages3
JournalAmerican Journal of Obstetrics and Gynecology
Volume192
Issue number5 SPEC. ISS.
DOIs
StatePublished - May 2005

Fingerprint

Hydatidiform Mole
Chorionic Gonadotropin
Gestational Trophoblastic Disease
Office Visits
Lost to Follow-Up

Keywords

  • Human chorionic gonadotropin
  • Molar pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Medicine(all)

Cite this

Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles. / Lavie, Isaac; Rao, Gautam G.; Castrillon, Diego H.; Miller, David S.; Schorge, John O.

In: American Journal of Obstetrics and Gynecology, Vol. 192, No. 5 SPEC. ISS., 05.2005, p. 1362-1364.

Research output: Contribution to journalArticle

@article{802534c383884d19a7262ddc471821c1,
title = "Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles",
abstract = "Objective: Partial hydatidiform moles infrequently progress to gestational trophoblastic neoplasia. The purpose of this study was to determine the optimal duration of human chorionic gonadotropin surveillance. Study design: We retrospectively reviewed the clinical follow-up of all women who were diagnosed with partial hydatidiform mole at our institution from 1983 to 2003. Results: One hundred sixty-three patients were identified with a median age of 23 years (range, 14-42 years). Seventy-four patients (45{\%}) attained undetectable levels of human chorionic gonadotropin; none of the patients had gestational trophoblastic neoplasia. Forty patients completed the 6 months of recommended follow-up; 6 patients conceived during surveillance, and 28 patients did not return for any further office visits 1 to 5 months after achieving remission. Eighty-three patients (51{\%}) were lost to follow-up before normalization of human chorionic gonadotropin. Six women (4{\%}) had stage I gestational trophoblastic neoplasia during surveillance. Conclusion: Our results support the suggestion that a single undetectable human chorionic gonadotropin level after evacuation is sufficient follow-up to ensure remission in patients with partial hydatidiform moles.",
keywords = "Human chorionic gonadotropin, Molar pregnancy",
author = "Isaac Lavie and Rao, {Gautam G.} and Castrillon, {Diego H.} and Miller, {David S.} and Schorge, {John O.}",
year = "2005",
month = "5",
doi = "10.1016/j.ajog.2004.12.080",
language = "English (US)",
volume = "192",
pages = "1362--1364",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "5 SPEC. ISS.",

}

TY - JOUR

T1 - Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles

AU - Lavie, Isaac

AU - Rao, Gautam G.

AU - Castrillon, Diego H.

AU - Miller, David S.

AU - Schorge, John O.

PY - 2005/5

Y1 - 2005/5

N2 - Objective: Partial hydatidiform moles infrequently progress to gestational trophoblastic neoplasia. The purpose of this study was to determine the optimal duration of human chorionic gonadotropin surveillance. Study design: We retrospectively reviewed the clinical follow-up of all women who were diagnosed with partial hydatidiform mole at our institution from 1983 to 2003. Results: One hundred sixty-three patients were identified with a median age of 23 years (range, 14-42 years). Seventy-four patients (45%) attained undetectable levels of human chorionic gonadotropin; none of the patients had gestational trophoblastic neoplasia. Forty patients completed the 6 months of recommended follow-up; 6 patients conceived during surveillance, and 28 patients did not return for any further office visits 1 to 5 months after achieving remission. Eighty-three patients (51%) were lost to follow-up before normalization of human chorionic gonadotropin. Six women (4%) had stage I gestational trophoblastic neoplasia during surveillance. Conclusion: Our results support the suggestion that a single undetectable human chorionic gonadotropin level after evacuation is sufficient follow-up to ensure remission in patients with partial hydatidiform moles.

AB - Objective: Partial hydatidiform moles infrequently progress to gestational trophoblastic neoplasia. The purpose of this study was to determine the optimal duration of human chorionic gonadotropin surveillance. Study design: We retrospectively reviewed the clinical follow-up of all women who were diagnosed with partial hydatidiform mole at our institution from 1983 to 2003. Results: One hundred sixty-three patients were identified with a median age of 23 years (range, 14-42 years). Seventy-four patients (45%) attained undetectable levels of human chorionic gonadotropin; none of the patients had gestational trophoblastic neoplasia. Forty patients completed the 6 months of recommended follow-up; 6 patients conceived during surveillance, and 28 patients did not return for any further office visits 1 to 5 months after achieving remission. Eighty-three patients (51%) were lost to follow-up before normalization of human chorionic gonadotropin. Six women (4%) had stage I gestational trophoblastic neoplasia during surveillance. Conclusion: Our results support the suggestion that a single undetectable human chorionic gonadotropin level after evacuation is sufficient follow-up to ensure remission in patients with partial hydatidiform moles.

KW - Human chorionic gonadotropin

KW - Molar pregnancy

UR - http://www.scopus.com/inward/record.url?scp=20644436710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20644436710&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2004.12.080

DO - 10.1016/j.ajog.2004.12.080

M3 - Article

VL - 192

SP - 1362

EP - 1364

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 5 SPEC. ISS.

ER -